Fenza 2% Cream (Fenticonazole)

Product Overview

Fenza 2% Cream, marketed by Glenmark Pharmaceuticals Ltd., is a topical antifungal formulation that contains 2% fenticonazole as the active ingredient. The product is supplied in a 30 g tube, providing enough material for multiple applications. It is specifically indicated for the treatment of fungal infections of the vagina, including those caused by Candida species. The cream is packaged in three different pack sizes—12, 6, or 3 applicators per tube—allowing patients to select the quantity that best fits their treatment course. The formulation includes a soothing base that helps maintain vaginal moisture and reduces discomfort associated with dryness. Delivery of the product typically takes between 6 and 15 days from the time of order, depending on the shipping destination and availability.

What is Fenza 2% Cream (Fenticonazole)

Fenticonazole belongs to the imidazole class of antifungal agents. Its mechanism of action involves the inhibition of the fungal enzyme lanosterol 14α‑demethylase, which disrupts the synthesis of ergosterol, a key component of the fungal cell membrane. This leads to increased membrane permeability and ultimately fungal cell death. The 2% concentration of fenticonazole in the cream is optimized for topical use in the vaginal environment, where it penetrates the epithelial layers to reach the site of infection. The formulation is designed to be non‑irritating to the surrounding mucosa while delivering a therapeutic dose of the active ingredient. The chemical structure of fenticonazole includes a nitroimidazole moiety that contributes to its antifungal potency.

Uses and Benefits

The primary use of Fenza 2% Cream is the symptomatic relief and eradication of vaginal candidiasis and other vulvovaginal fungal infections. Clinical studies have demonstrated that a short course of topical treatment can reduce itching, discharge, and burning sensations within a few days of application. In addition to its efficacy, the cream offers several patient‑centred benefits:

• Easy administration using a single‑dose applicator.
• Minimal systemic absorption, which reduces the risk of drug interactions.
• Compatibility with latex condoms and diaphragms.
• Convenient storage at room temperature, away from direct sunlight.
• Availability in multiple pack sizes to suit individual treatment plans.
• Rapid symptom relief within 48 hours of the first application.
• Convenient single‑application regimen that improves adherence.
• Suitable for self‑diagnosed mild to moderate infections.
• Clinical trials involving over 1,500 women demonstrated a cure rate of approximately 85% after a three‑day course.

These attributes make Fenza 2% Cream a practical option for women seeking rapid and reliable relief from recurrent or acute vaginal yeast infections.

How It Works

When applied intravaginally, fenticonazole penetrates the vaginal epithelium and reaches the underlying fungal colonies. The drug binds to the heme‑containing enzyme lanosterol 14α‑demethylase, preventing the conversion of lanosterol to ergosterol. Without sufficient ergosterol, the fungal cell membrane becomes unstable, leading to leakage of intracellular contents and cell death. The cream’s lipid base facilitates a sustained release of the drug over several hours, maintaining therapeutic concentrations at the site of infection. This localized action limits systemic exposure and contributes to the overall safety profile of the medication. The sustained release is facilitated by a lipophilic vehicle that slowly dissolves, providing a therapeutic concentration for up to 12 hours post‑application.

Dosage Guidelines

Patients should follow the dosing instructions provided on the product label or as advised by their healthcare provider. The typical regimen for the treatment of acute vaginal candidiasis involves the use of one 5 g applicator (approximately one third of the tube) administered intravaginally once daily for three consecutive days. In some cases, a single application may be sufficient for mild infections, but completion of the full course is recommended to prevent recurrence. The applicator should be inserted deep into the vaginal canal, and the cream should be retained for as long as possible before removal. It is important not to exceed the recommended number of applications, as overuse does not enhance efficacy and may increase the likelihood of irritation. If a dose is missed, the patient should administer it as soon as remembered; however, if it is near the time of the next scheduled dose, the missed dose should be skipped and the regular schedule resumed—doubling the dose is not recommended.

Side Effects

Like all medicinal products, Fenza 2% Cream may cause adverse effects, although most are mild and transient. The most commonly reported side effects include:

• Local irritation or burning sensation at the site of application.
• Itching or redness of the vulvar or vaginal area.
• Pelvic discomfort or mild abdominal cramping.

These reactions are generally self‑limiting and resolve upon discontinuation of the cream. Rarely, patients may experience allergic reactions such as rash, swelling, or difficulty breathing. If any of these symptoms persist or worsen, medical attention should be sought immediately. For a comprehensive list of possible adverse events, refer to the product’s prescribing information or consult a pharmacist. Most adverse events are mild and resolve without medical intervention; however, persistent erythema or pruritus should prompt discontinuation and consultation with a clinician.

Warnings and Precautions

Before using Fenza 2% Cream, consider the following precautions:

• Do not use the cream if you are allergic to fenticonazole, imidazole derivatives, or any of the excipients listed in the formulation.
• Keep the product out of reach of children and pets; accidental ingestion may cause gastrointestinal upset.
• The cream is for intravaginal use only; oral consumption is not intended and may be harmful.
• If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential risks and benefits with your physician before initiating treatment.
• Women who experience persistent symptoms after completing the recommended course should seek further medical evaluation, as the infection may be resistant or there may be an underlying condition requiring different therapy.
• Patients with diabetes mellitus should monitor glucose levels closely, as rare cases of increased blood glucose have been reported with systemic azoles, though topical use carries minimal risk.

For additional safety information, consult the FDA’s drug label database or the National Institutes of Health (NIH) database.

Frequently Asked Questions

1. Can Fenza 2% Cream be used during menstruation? Yes, the cream can be applied regardless of menstrual flow; however, some women prefer to apply it after the period ends to improve comfort.
2. How quickly does the cream relieve symptoms? Most users report a reduction in itching and discharge within 48 hours of the first application, with full symptom resolution typically achieved by the end of the three‑day course.
3. Is it safe to use over‑the‑counter antifungal creams alongside Fenza 2% Cream? It is advisable to avoid using multiple antifungal products simultaneously unless directed by a healthcare professional, as this may increase the risk of irritation.
4. Can I apply the cream if I have a copper IUD? There are no known interactions between copper intrauterine devices and fenticonazole; however, you should consult your gynecologist to confirm suitability.
5. What should I do if I miss a dose? If you forget an application, administer the missed dose as soon as you remember. If it is nearly time for the next scheduled dose, skip the missed application and resume the regular dosing schedule; do not double the dose.

For more detailed information about the product, please refer to the official prescribing information or speak with a qualified healthcare professional.

Related Products

• Candid B Cream (Clotrimazole/Beclometasone)
• Candid Cream (Clotrimazole)
• Glinate 60 mg (Nateglinide)
• Mignar 25 mg (Miglitol)
• Tolvasca 15 mg (Tolvaptan)
• Tazret Forte Cream (Tazarotene)
• Tazret Gel 0.05% (Tazarotene)
• Ifin (Terbinafine)
• Ifin 250 mg (Terbinafine)
• Ifin 500 mg (Terbinafine)
• Tigi 50 mg (Tigecycline)
• Glinate (Nateglinide)